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Quadricuspid aortic valve with aortic insufficiency: a rare
echocardiographic finding
Zachary Demertzis DO, Paul Nona MD, Bryan Zweig MD
Department Internal Medicine and Division of Cardiology Henry Ford Health System, Detroit, Michigan

Introduction

Images

• Quadriscupid aortic valve (QAV) is a rare congenital heart
defect typically found incidentally without any associated
cardiac defects
• Functional status of QAV is pure aortic insufficiency (AI)
• Clinical manifestations are dependent on the functional status of
the valve, presenting in the fifth or sixth decade of life due to
progressive degeneration of the leaflets
• In our case, we present a young female who developed postpartum dyspnea with elevated brain natriuretic peptide levels
concerning for heart failure where on
transesophageal echocardiography (TEE) revealed a QAV with
AI
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Case Presentation
Patient: 37-year-old female with no
5 days post cesarean section
Chief Complaint: dyspnea (NYHA III)
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Physical examination: significant for decrescendo diastolic murmur at
the aortic area and bibasilar rales

Conclusion
• QAV is a rare, isolated congenital disease

Pertinent labs: brain natriuretic peptide level elevation of 345 pg/mL
with normal troponin I levels (<40 ng/L)
Imaging:
• Chest radiograph significant for pulmonary congestion
• Transthoracic echocardiogram was suggestive for AI
• Transesophageal echocardiogram revealed a QAV with all four
leaflets equal in size with
normal
thickness
and
mobility. Moderate malcoaptation of all valves was present and
severe AI was visualized. Planimetry of aortic regurgitant
orifice was measure at 0.29 cm2, the AI jet was greater than 65%
of
left
ventricular
outflow
tract,
pressure
half
time
calculated
at
252
ms,
and
vena contracta measured 0.6 cm.
Her systolic (ejection
fraction 60%) and diastolic function were both preserved.

• Most commonly manifests with AI in the fifth and sixth decade
• QAV is typically found incidentally and best visualized by TEE
• Definitive management of QAV is surgical valve replacement

Figure 3
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Management:
• She was diuresed with furosemide 40 mg IV twice daily, achieving
euvolemia and symptom relief, discharged on furosemide 20mg PO
daily
Post-Hospitalization:
• Seen by structural heart and cardiac surgery team, recommended to
undergo CT coronary angiography for surgical aortic valve
replacement, but lost to follow up

QAV is a rare congenital cardiac anomaly with an incidence
rate of 0.00028-0.00033%
Echocardiography allowed for visualization of the aortic
valve and for quantification of the degree of AI
QAV can present in various anatomic morphologies and can
be further classified
Most prevalent complication of QAV is AI (74.7%)
Untreated AI can lead to valvular heart failure
Patients with QAV are at increased risk for infective
endocarditis due to progressive degeneration of the leaflets
from the asymmetric mechanical stress around the four cusps
In our case, the peripartum physiologic changes of increased
intravascular volume lead to further valvular stress resulting in
acute valvular heart failure
Definitive treatment of QAV with AI is valve replacement,
which was recommended to our patient

Figure 1. Transesophageal echocardiogram. Mid-esophageal level, aortic
valve short axis view. Doppler significant for severe AI.
Figure 2. Hurwitz & Roberts classification of QAV with Vali et al.
supplementation
Figure 3.

Nakamura et al. simplified classification of QAV
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